We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Lysosomal Activity Changes as Dendritic Cells Mature

By Biotechdaily staff writers
Posted on 24 Mar 2003
Researchers have found that as dendritic cells mature, a physiologic change occurs in their lysosomes, digestive vacuoles within the cytoplasm that facilitate the efficient formation of peptide-MHC class II complexes on the surface of the cells. More...
Their findings were published in the March 7, 2003, issue of Science.

Dendritic cells are the most potent antigen-presenting cells involved in host defense. All immunogenic and tolerogenic responses are initiated upon the recognition of antigen presented by mature dendritic cells, playing an important role in the immune response in cancer and autoimmune diseases.

In response to a variety of stimuli, dendritic cells transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. The physiologic basis of this maturation process was not well understood.

In the current study, investigators from Yale University's Ludwig Cancer Institute (New Haven, CT, USA; www.yale.edu) showed that dendritic cell maturation was accompanied by an acidic shift in lysosomes that favored the production of immune stimulating molecules. In general, lysosomes quickly destroy internalized proteins from bacteria, viruses, or cancer cells and then convert them into individual amino acids that are too small to be recognized by the immune system. However, in mature dendritic cells antigens are sequestered in the lysosomes and then degraded into peptide fragments that are 10-to-15 amino acids in length. These fragments then bind to other molecules, which transport them from lysosomes to the surface of cells.

"Despite rather unfavorable conditions, mature dendritic cells are able to use their lysosomes to warn the immune system,” explained senior author Dr. Ira Mellman, a researcher in the department of cell biology at Yale University School of Medicine. "For 50 years, we have been taught that lysosomes simply degrade all protein they encounter, a situation which would prevent the formation of the large protein fragments required to generate immunity. Dendritic cells have contrived a way around the conventional view of lysosomes by controlling their activities.”

"The fact that lysosomes appear developmentally controlled would explain a key feature of why dendritic cells are so good at what they do,” added Dr. Mellman.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.